1921
Volume 88, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Yellow fever (YF) vaccine-associated serious adverse events and changing YF epidemiology have challenged healthcare providers to vaccinate only travelers whose risk of YF during travel is greater than their risk of adverse events. We describe the travel characteristics and YF vaccine use among US travelers visiting Global TravEpiNet clinics from January of 2009 to March of 2011. Of 16,660 travelers, 5,588 (34%) had itineraries to areas with risk of YF virus transmission. Of those travelers visiting one country with YF risk ( = 4,517), 71% were vaccinated at the visit, and 20% were presumed to be immune from prior vaccination. However, travelers visiting friends and relatives (odds ratio [OR] = 2.57, 95% confidence interval [95% CI] = 1.27–5.22) or going to Nigeria (OR = 3.01, 95% CI = 1.37–6.62) were significantly more likely to decline vaccination. To optimize YF vaccine use, clinicians should discuss an individual's risk–benefit assessment of vaccination and close knowledge gaps regarding vaccine use among at-risk populations.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.12-0463
2013-05-01
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/88/5/954.html?itemId=/content/journals/10.4269/ajtmh.12-0463&mimeType=html&fmt=ahah

References

  1. Monath TP, Gershman M, Staples JE, Barrett ADT, Plotkin SA, Orenstein W, Offit PA, , 2012. Yellow fever vaccine. , eds. Vaccines. Philadelphia, PA: WB Saunders, 870968.
  2. Staples JE, Gershman M, Fischer M, , 2010. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59: 127.
  3. Gubler DJ, , 2002. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33: 330342.[Crossref]
  4. WHO, 2008. Outbreak news. Yellow fever, Paraguay. Wkly Epidemiol Rec 83: 105.
  5. WHO, 2011. Outbreak news. Yellow fever, Uganda. Wkly Epidemiol Rec 86: 3738.
  6. WHO, 2012. Yellow fever in Cameroon. Communicable Disease Surveillance and Response (CSR). Available at: http://www.who.int/csr/don/2012_02_03/en/index.html. Accessed March 13, 2012.
  7. UNWTO, 2011. UNWTO Tourism Highlights, 2011 Edition. Available at: http://mkt.unwto.org/sites/all/files/docpdf/unwtohighlights11enlr_1.pdf. Accessed December 28, 2012.
  8. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, , 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 60776082.[Crossref]
  9. Seligman SJ, , 2011. Yellow fever virus vaccine-associated deaths in young women. Emerg Infect Dis 17: 18911893.[Crossref]
  10. LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J, Connor BA, Goad J, Oladele A, Alvarez S, Stauffer W, Walker P, Kozarsky P, Franco-Paredes C, Dismukes R, Rosen J, Hynes NA, Jacquerioz F, McLellan S, Hale D, Sofarelli T, Schoenfeld D, Marano N, Brunette G, Jentes ES, Yanni E, Sotir MJ, Ryan ET, the Global TravEpiNet Consortium; , 2011. Demographics, travel destinations, and pre-travel health care among U.S. international travelers in Global TravEpiNet. Clin Infect Dis 54: 455462.[Crossref]
  11. Centers for Disease Control and Prevention, 2011. Health Information for International Travel, 2012. Atlanta, GA: US Department of Health and Human Services, Public Health Service.
  12. Jentes ES, Poumerol G, Gershman MD, Hill DR, Lemarchand J, Lewis RF, Staples JE, Tomori O, Wilder-Smith A, Monath TP, , 2011. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis 11: 622632.[Crossref]
  13. WHO, 2011. International Travel and Health. Geneva: World Health Organization.
  14. Gershman M, Schroeder B, Jentes ES, Marano N, Brunette GW, , 2009. Yellow fever vaccine requirements and recommendations, by country. , ed. CDC Health Information for International Travel 2010. Atlanta, GA: US Public Health Service.
  15. Anonymous, 2009. World Development Report 2009: Reshaping Economic Geography. Available at: http://siteresources.worldbank.org/INTRANETTRADE/Resources/Internal-Training/WDR_2009_Reshaping_Economic_Georgraphy.pdf. Accessed January 7, 2013.
  16. Morel JG, Bokossa MC, Neerchal NK, , 2003. Small sample correction for the variance of GEE estimators. Biom J 45: 395409.[Crossref]
  17. Toovey S, Jamieson A, Holloway M, , 2004. Travelers' knowledge, attitudes and practices on the prevention of infectious diseases: results from a study at Johannesburg International Airport. J Travel Med 11: 1622.[Crossref]
  18. Hagmann S, Benavides V, Neugebauer R, Purswani M, , 2009. Travel health care for immigrant children visiting friends and relatives abroad: retrospective analysis of a hospital-based travel health service in a US urban underserved area. J Travel Med 16: 407412.[Crossref]
  19. LaRocque R, Rao S, Tsibris A, Lawton T, Barry MA, Marano N, Brunette G, Yanni E, Ryan E, , 2010. Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med 17: 387391.[Crossref]
  20. Angell S, Cetron M, , 2005. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med 142: 6772.[Crossref]
  21. Bacaner N, Stauffer B, Boulware D, Walker P, Keystone J, , 2004. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 291: 28562864.[Crossref]
  22. Leder K, Chen LH, Wilson ME, , 2012. Aggregate travel vs. single trip assessment: arguments for cumulative risk analysis. Vaccine 30: 26002604.[Crossref]
  23. Anonymous, 2011. WHO: Yellow Fever Reported Cases. Available at: http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidenceyfe.htm. Accessed January 24, 2012.
  24. Monath TP, Cetron MS, , 2002. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 13691378.[Crossref]
  25. Monath TP, , 2012. Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert Rev Vaccines 11: 427448.[Crossref]
  26. WHO, 2008. Update on progress controlling yellow fever in Africa 2004–2008. Wkly Epidemiol Rec 83: 449460.
  27. Schilthuis H, Goossens I, Ligthelm R, de Vlas S, Varkevisser C, Richardus J, , 2007. Factors determining use of pre-travel preventive health services by West African immigrants in The Netherlands. Trop Med Int Health 12: 990998.[Crossref]
  28. Hamer D, Connor B, , 2004. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med 11: 2326.[Crossref]
  29. FDA, 2012. Biologic Product Shortages. Available at: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/Shortages/default.htm. Accessed March 28, 2012.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.12-0463
Loading
/content/journals/10.4269/ajtmh.12-0463
Loading

Data & Media loading...

  • Received : 31 Jul 2012
  • Accepted : 26 Jan 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error